Applied Filters
UK firm successfully challenges ‘Vagisan’ TM in Singapore
UK-based pharmaceutical manufacturer Comb International, owner of the ‘Vagisil’ trademark, has successfully challenged the ‘Vagisan’ trademark at the Intellectual Property Office Singapore.
China approves three Gilead remdesivir patents for COVID-19 treatment
US-based Gilead Sciences has been granted three Chinese patents connected to possible COVID-19 treatment remdesivir, reported He Zhimin, the deputy director of China’s National Intellectual Property Administration.
Sanofi to create ‘world’s second biggest’ API manufacturer
French drugmaker Sanofi is looking to create a new European manufacturer of active pharmaceutical ingredients, amid concerns over dependence on a Chinese manufacturing sector hit by coronavirus.
GSK and Chinese biotech unite for coronavirus vaccine development
British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate.
Gilead fails to have US government patents invalidated
Gilead Sciences has failed in its efforts to have US government patents covering the use of HIV drugs as pre-exposure prophylaxis invalidated.
Irish nutrition group faces Kaneka patent suit
Japanese drugmaker Kaneka has accused Irish nutrition company Glanbia of infringing two patents with its ActiQuinol antioxidant products.
3M drops IBM healthcare software suit
US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit.
Health campaigners call for greater checks on AbbVie/Allergan merger
Trade unions and consumer groups have urged the Federal Trade Commission to intervene in the planned $63 billion merger of drugmakers AbbVie and Allergan, arguing it would “substantially harm competition”.
Sanofi partners with HHS to work on COVID-19 vaccine
Sanofi’s vaccine unit has united with the US Department of Health and Human Services to develop a vaccine for the COVID-19 virus, which has so far killed more than 2,000 people worldwide.
Eli Lilly claims another victory in Taltz patent battle
The English High Court has invalidated key claims of a patent owned by Roche subsidiary Genentech, following a lawsuit filed by US rival Eli Lilly.
